185 related articles for article (PubMed ID: 19725779)
21. Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.
Jin L; Burniat A; Dumont JE; Miot F; Corvilain B; Franc B
Br J Cancer; 2008 Dec; 99(11):1874-83. PubMed ID: 18985036
[TBL] [Abstract][Full Text] [Related]
22. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).
Nakazawa T; Kondo T; Kobayashi Y; Takamura N; Murata S; Kameyama K; Muramatsu A; Ito K; Kobayashi M; Katoh R
Cancer; 2005 Sep; 104(5):943-51. PubMed ID: 16015630
[TBL] [Abstract][Full Text] [Related]
23. Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1.
Moretti S; Menicali E; Nucci N; Voce P; Colella R; Melillo RM; Liotti F; Morelli S; Fallarino F; Macchiarulo A; Santoro M; Avenia N; Puxeddu E
J Biol Chem; 2017 Feb; 292(5):1785-1797. PubMed ID: 27994058
[TBL] [Abstract][Full Text] [Related]
24. The effects of four different tyrosine kinase inhibitors on medullary and papillary thyroid cancer cells.
Verbeek HH; Alves MM; de Groot JW; Osinga J; Plukker JT; Links TP; Hofstra RM
J Clin Endocrinol Metab; 2011 Jun; 96(6):E991-5. PubMed ID: 21470995
[TBL] [Abstract][Full Text] [Related]
25. RET receptor expression in thyroid follicular epithelial cell-derived tumors.
Bunone G; Uggeri M; Mondellini P; Pierotti MA; Bongarzone I
Cancer Res; 2000 Jun; 60(11):2845-9. PubMed ID: 10850426
[TBL] [Abstract][Full Text] [Related]
26. Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.
Castellone MD; Cirafici AM; De Vita G; De Falco V; Malorni L; Tallini G; Fagin JA; Fusco A; Melillo RM; Santoro M
Oncogene; 2003 Jan; 22(2):246-55. PubMed ID: 12527893
[TBL] [Abstract][Full Text] [Related]
27. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.
Borrello MG; Alberti L; Fischer A; Degl'innocenti D; Ferrario C; Gariboldi M; Marchesi F; Allavena P; Greco A; Collini P; Pilotti S; Cassinelli G; Bressan P; Fugazzola L; Mantovani A; Pierotti MA
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14825-30. PubMed ID: 16203990
[TBL] [Abstract][Full Text] [Related]
28. An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases.
Kim DW; Jo YS; Jung HS; Chung HK; Song JH; Park KC; Park SH; Hwang JH; Rha SY; Kweon GR; Lee SJ; Jo KW; Shong M
J Clin Endocrinol Metab; 2006 Oct; 91(10):4070-6. PubMed ID: 16849418
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma.
Caria P; Dettori T; Frau DV; Di Oto E; Morandi L; Parmeggiani A; Tallini G; Vanni R
Am J Surg Pathol; 2012 Sep; 36(9):1415-20. PubMed ID: 22895275
[TBL] [Abstract][Full Text] [Related]
30. Histopathological changes induced by selective inactivation of menin on the thyroid gland in RET÷PTC3 and E7 transgenic mice. A study of 77 cases.
Căpraru OM; Berger N; Gadot N; Decaussin-Petrucci M; Zhang C; Borda A; Szilágyi T; Borson-Chazot F; Selmi-Ruby S
Rom J Morphol Embryol; 2016; 57(1):91-8. PubMed ID: 27151693
[TBL] [Abstract][Full Text] [Related]
31. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
[TBL] [Abstract][Full Text] [Related]
32. Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation.
Caudill CM; Zhu Z; Ciampi R; Stringer JR; Nikiforov YE
J Clin Endocrinol Metab; 2005 Apr; 90(4):2364-9. PubMed ID: 15671095
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
[TBL] [Abstract][Full Text] [Related]
34. The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.
Melillo RM; Castellone MD; Guarino V; De Falco V; Cirafici AM; Salvatore G; Caiazzo F; Basolo F; Giannini R; Kruhoffer M; Orntoft T; Fusco A; Santoro M
J Clin Invest; 2005 Apr; 115(4):1068-81. PubMed ID: 15761501
[TBL] [Abstract][Full Text] [Related]
35. Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin.
Lakshmanan A; Scarberry D; Green JA; Zhang X; Selmi-Ruby S; Jhiang SM
Oncotarget; 2015 Oct; 6(31):31792-804. PubMed ID: 26397139
[TBL] [Abstract][Full Text] [Related]
36. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
[TBL] [Abstract][Full Text] [Related]
37. Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene.
Iavarone C; Acunzo M; Carlomagno F; Catania A; Melillo RM; Carlomagno SM; Santoro M; Chiariello M
J Biol Chem; 2006 Apr; 281(15):10567-76. PubMed ID: 16484222
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of the expression of RET/PTC oncogenes in post-chernobyl papillary thyroid carcinomas of patients from different age groups].
Voskoboĭnik LG; Kostiuchenko NM; Pushkar'ov VM; Bogdanova TI; Tron'ko MD
Ukr Biokhim Zh (1999); 2010; 82(5):79-84. PubMed ID: 21674964
[TBL] [Abstract][Full Text] [Related]
39. Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima.
Iyama K; Matsuse M; Mitsutake N; Rogounovitch T; Saenko V; Suzuki K; Ashizawa M; Ookouchi C; Suzuki S; Mizunuma H; Fukushima T; Suzuki S; Yamashita S
Thyroid; 2017 Jun; 27(6):811-818. PubMed ID: 28351223
[TBL] [Abstract][Full Text] [Related]
40. Human papilloma virus 16 E7 oncogene does not cooperate with RET/PTC 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice.
Portella G; Borselli C; Santoro M; Gerbasio D; D'Armiento MR; Dumont JE; Ledent C; Rothstein JL; Vecchio G; Fusco A
Oncol Res; 2001; 12(8):347-54. PubMed ID: 11589306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
